A Randomized Phase II Trial Evaluating Different Schedules of Zoledronic Acid on Bone Mineral Density in Patients With Prostate Cancer Beginning Androgen Deprivation Therapy
Clinical Genitourinary Cancer - United States
doi 10.1016/j.clgc.2013.04.029
Full Text
Open PDFAbstract
Available in full text
Date
December 1, 2013
Authors
Publisher
Elsevier BV